CDK2 and ovarian carcinoma: It has been shown that CDK2 is dispensable for tumorigenesis induced by the loss of p53 in mice [100] but its depletion rescues the DNA damage induced by premature activation of CDK1 due to WEE1 inhibition in breast and ovarian cancer cell lines [35].